Is there a need to optimize glycemic control in hemodialyzed diabetic patients?
The report of Williams et al. gives rise to at least two important questions regarding diabetic patients on maintenance hemodialysis: (1) Does glycemic control play a significant role? (2) Is HbA1c a reliable measure of glycemic control? These questions are discussed. It is recommended that you treat ESRD patients with diabetes according to guidelines given for patients without ESRD.
Feldt-Rasmussen
B
B
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. bfr@rh.dk
D001786:Blood Glucose / Q000032:analysis*; D048909:Diabetes Complications / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000517:prevention & control; D007003:Hypoglycemia / Q000097:blood / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000097:blood / Q000209:etiology / Q000628:therapy; D006435:Renal Dialysis; D012307:Risk Factors
D001786:Blood Glucose; D006442:Glycated Hemoglobin